Frontlight ResearchEarly access
Trial site
Istituto Europeo di Oncologia - Milano
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Colorectal cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Chronic lymphocytic leukaemia1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Status
- Recruiting5 trials
- Active, not recruiting1 trial
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto3 trials
- Fondazione G.I.M.Em.A Franco Mandelli Ets1 trial
- Gruppo Oncologico Italia Meridionale1 trial
- IRCCS Istituto Nazionale Tumori Fondazione Pascale1 trial
Running trials
Recruiting
Recruiting
Recruiting
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
Active, not recruiting
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
Active, not recruiting
Recruiting
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026